DrugPatentWatch Database Preview
Drugs in Development Information for PQR309
Email this page to a colleague
See Plans and PricingWhat is the development status for investigational drug PQR309?
PQR309 is an investigational drug.
There have been 9 clinical trials for PQR309.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 15th 2017.
The most common disease conditions in clinical trials are Lymphoma, Breast Neoplasms, and Lymphoma, Non-Hodgkin. The leading clinical trial sponsors are PIQUR Therapeutics AG, University Hospital, Basel, Switzerland, and Roswell Park Cancer Institute.
There are three US patents protecting this investigational drug and forty-four international patents.
Summary for PQR309
| US Patents | 3 |
| International Patents | 44 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-06-15) |
| Vendors | 28 |
Recent Clinical Trials for PQR309
| Title | Sponsor | Phase |
|---|---|---|
| Study Evaluating Safety and Efficacy of Bimiralisib in Patients With Head and Neck Squameous Cell Carcinoma | PIQUR Therapeutics AG | Phase 2 |
| PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma | PIQUR Therapeutics AG | Phase 2 |
| Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients | Charite University, Berlin, Germany | Phase 2 |
Clinical Trial Summary for PQR309
Top disease conditions for PQR309
Top clinical trial sponsors for PQR309
US Patents for PQR309
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PQR309 | Start Trial | Manufacturing process for triazine, pyrimidine and pyridine derivatives | UNIVERSITAET BASEL (Basel, CH) PIQUR THERAPEUTICS AG (Basel, CH) | Start Trial |
| PQR309 | Start Trial | Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes | University of Basel (Basel, CH) | Start Trial |
| PQR309 | Start Trial | Triazine compounds | Sphaera Pharma PTE. Ltd. (Singapore, SG) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PQR309
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PQR309 | Australia | 2015250994 | 2034-04-22 | Start Trial |
| PQR309 | Brazil | 112016023811 | 2034-04-22 | Start Trial |
| PQR309 | Canada | 2944697 | 2034-04-22 | Start Trial |
| PQR309 | China | 106458968 | 2034-04-22 | Start Trial |
| PQR309 | European Patent Office | 3134388 | 2034-04-22 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
